Failure to adequately investigate, correct, and prevent recurring problem of distributing blood and blood components without ice to consignees.
Inspection Record
American Red Cross Blood Services — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Failure to sign and date equipment validation/revalidation records.
", Written procedure was not followed regarding handling of "Management of Suspect Products".
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
